| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |